News

Paul Vibert, general manager of Baxter China said: “the investment represents the company’s commitment to China and that he expects that the company can achieve double-digit sales growth

Manufacturing a vaccine from the present strain of the virus entails some risk, as the virus is capable of mutating into a form that can turn the vaccine

In its complaint, Onyx seeks a declaration that fluoro-sorafenib is a jointly-owned collaboration compound under the Bayer/Onyx collaboration agreement, together with other remedies. Onyx affirmed that it continues

Medicis, a US based Aesthetics company, known for facial fillers like Restylane and Perlane will promote Dysport in the US as part of a sales agreement with the

Architect CORE is a chemiluminescent microparticle immunoassay (CMIA) used to detect IgG and IgM antibodies to hepatitis B core antigen (anti-HBc). The company includes hepatitis B test to

SDSU researchers lead by Chandradhar Dwivedi, Head, Department of Pharmaceutical Sciences, SDSU have found that treating human skin cancer cells with various concentrations of sarcophine-diol has inhibited the

Alkermes, a biotechnology company, has initiated two new clinical trials of ALKS 33, an oral opioid modulator for the potential treatment of addiction and other nervous system disorders.

Addrenex Pharmaceuticals, a specialty pharmaceutical company, has signed an agreement to license a new drug for the treatment of narcolepsy, as well as other neurologic and psychiatric conditions.

Lipoxen, a UK-based developer of drug and vaccine delivery systems, has received funding to apply its ImuXen technology to enhance the performance of malaria vaccine candidates. The PATH